InStride Secures $30 Million Series C to Broaden Pediatric Mental‑Health Services

InStride Health announced Monday that it has closed a $30 million Series C financing round to accelerate its expansion across the United States.

Based in Boston, InStride delivers virtual specialty outpatient care for children and young adults dealing with anxiety and obsessive‑compulsive disorder. The program is rooted in cognitive‑behavioral therapy, emphasizing exposure techniques that gradually confront feared situations. Patients aged seven to 24 receive a coordinated care team—including a therapist, an exposure coach, and a psychiatrist—who create personalized treatment plans and stay connected with the patient via text, phone, or video.

The new round was led by Echo Health Ventures and FMZ Ventures, with continued participation from .406 Ventures, Valtruis, General Catalyst and Mass General Brigham Ventures.

“As behavioral health shifts from mere access to measurable outcomes, high‑quality specialty models like InStride are exceptionally positioned,” said Kurt Sheline, partner at Echo Health Ventures. “They have built wrap‑around care and incentive structures that deliver sustainable returns to payors and have proven the model’s scalability across multiple markets. We are thrilled to back the company in its next growth phase.”

John Voith, co‑founder and CEO, said the capital will fund entry into new states while deepening services in existing ones. InStride currently operates in 17 states and has treated more than 5,000 patients.

“The investment will enable us to add specialty capacity for payors and employers in regions where evidence‑based care for complex anxiety, OCD, and related disorders is scarce, removing geography and insurance status as barriers,” Voith explained. “Most importantly, it will allow more young people to receive high‑quality specialty treatment, complete care successfully, and thrive.”

Recent outcome data show that 97 % of program graduates report overall clinical improvement, and over 99 % remain out of the hospital one year after discharge. Additionally, 81 % of caregivers note reduced personal stress, and more than 90 % report fewer missed work days.

Voith added that the company’s long‑term goal is to broaden access to evidence‑based specialty care for youth while preserving the strong clinical results that define InStride’s approach.

Other firms operating in the pediatric mental‑health space include Brightline and Little Otter.

Source link